Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats

Qin Zhi Gong, Thérèse M. Delahunty, Robert J. Hamm, Bruce G Lyeth

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


The metabotropic glutamate receptor (mGluR) antagonist, α-methyl-4-car{ballot box}yphenylglycine (MCPG) was administered into the left lateral ventricle 5 min prior to fluid percussion traumatic brain injury (TBI) in the rat. A single 5.0 μl ventricular infusion of the active isomer, (+)-MCPG (0.2 μmol), significantly reduced beam walking motor deficits on days 1-5 after injury and learning/memory deficits measured on days 11-15 after injury. Neither a lower dose of (+)-MCPG (0.02 μmol) nor the relatively inactive isomer, (-)-MCPG (0.2 μmol) affected behavioral outcome. (+)-MCPG (0.2 μmol) did not affect systemic hemodynamic responses to injury. These results suggest that TBI induced activation of mGluRs contributes to behavioral morbidity and that blockade of certain mGluR subtypes (mGluR1, mGluR5 and/or mGluR2) may reduce these pathophysiological responses.

Original languageEnglish (US)
Pages (from-to)299-302
Number of pages4
JournalBrain Research
Issue number1-2
StatePublished - Nov 27 1995
Externally publishedYes


  • Fluid percussion
  • Metabotropic glutamate receptor
  • Morbidity
  • Phenylglycine
  • Rat
  • Traumatic brain injury
  • α-Methyl-4-car{ballot box}yphenylglycine

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)


Dive into the research topics of 'Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats'. Together they form a unique fingerprint.

Cite this